Skip to main content
Top
Published in: Endocrine 3/2019

01-12-2019 | Diabetic Retinopathy | Original Article

Spectral domain optical coherence tomography based imaging biomarkers for diabetic retinopathy

Authors: Sandeep Saxena, Martin Caprnda, Surabhi Ruia, Senthamizh Prasad, Ankita, Julia Fedotova, Peter Kruzliak, Vladimir Krasnik

Published in: Endocrine | Issue 3/2019

Login to get access

Abstract

To evaluate the role of central subfield thickness (CST), cube average thickness (CAT), and cube volume (CV) as imaging biomarkers for severity of diabetic retinopathy within the ETDRS-based grades of retinopathy using spectral domain optical coherence tomography (SD-OCT). This study aims to evaluate the role of macular CST, CAT, and CV on SD-OCT as imaging biomarkers for severity of DR. One hundred ninety-four consecutive cases of type 2 diabetes mellitus were divided according to ETDRS classification: diabetes mellitus without retinopathy (No DR; n = 65), nonproliferative diabetic retinopathy (NPDR; n = 66), and proliferative diabetic retinopathy (PDR; n = 63). Sixty-three healthy controls were included. CST, CAT, and CV were analyzed using SD-OCT. Data were analyzed statistically. Analysis of variance revealed a significant increase in levels of CST, CAT, CV, and LogMAR visual acuity with the increase in severity of DR. Independent t-test revealed significant difference in CST, CAT, and CV between cases with DME and cases without DME. On multivariate linear regression analysis, increase in CST, CAT, and CV were found to indicate the increase in severity of DR. SD-OCT-based imaging biomarkers CST, CAT, and CV are effective tools for documenting the severity of diabetic retinopathy. These imaging biomarkers serve as significant indicators of severity of disease.
Literature
1.
go back to reference H. King, R.E. Aubert, W.H. Herman, Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 21, 1414–1431 (1998)CrossRef H. King, R.E. Aubert, W.H. Herman, Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 21, 1414–1431 (1998)CrossRef
2.
go back to reference D.S. Fong, L. Aiello, T.W. Gardner, G.L. King, G. Blankenship, J.D. Cavallerano, F.L. Ferris 3rd, American Diabetes Association, Retinopathy in diabetes. Diabetes Care. 27, 84–87 (2004)CrossRef D.S. Fong, L. Aiello, T.W. Gardner, G.L. King, G. Blankenship, J.D. Cavallerano, F.L. Ferris 3rd, American Diabetes Association, Retinopathy in diabetes. Diabetes Care. 27, 84–87 (2004)CrossRef
3.
go back to reference A.M. Joussen, V. Poulaki, W. Qin, B. Kirchhof, N. Mitsiades, S.J. Wiegand, J. Rudge, G.D. Yancopoulos, A.P. Adamis, Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am. J. Pathol. 160, 501–509 (2002)CrossRef A.M. Joussen, V. Poulaki, W. Qin, B. Kirchhof, N. Mitsiades, S.J. Wiegand, J. Rudge, G.D. Yancopoulos, A.P. Adamis, Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am. J. Pathol. 160, 501–509 (2002)CrossRef
4.
go back to reference B.O. Boehm, S. Schilling, S. Rosinger, G.E. Lang, G.K. Lang, R. Kientsch-Engel, P. Stahl, Elevated serum levels of N ε-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema. Diabetologia 47, 1376–1379 (2004)CrossRef B.O. Boehm, S. Schilling, S. Rosinger, G.E. Lang, G.K. Lang, R. Kientsch-Engel, P. Stahl, Elevated serum levels of N ε-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema. Diabetologia 47, 1376–1379 (2004)CrossRef
5.
go back to reference Ankita, S. Saxena, D.K. Nim, J. Stefanickova, P. Ziak, P. Stefanicka, P. Kruzliak, Retinal photoreceptor apoptosis is associated with impaired serum ionized calcium homeostasis in diabetic retinopathy: An in-vivo analysis. J. Diabetes Complicat. 33, 208–211 (2019)CrossRef Ankita, S. Saxena, D.K. Nim, J. Stefanickova, P. Ziak, P. Stefanicka, P. Kruzliak, Retinal photoreceptor apoptosis is associated with impaired serum ionized calcium homeostasis in diabetic retinopathy: An in-vivo analysis. J. Diabetes Complicat. 33, 208–211 (2019)CrossRef
6.
go back to reference Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89–95 (2001)CrossRef Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89–95 (2001)CrossRef
7.
go back to reference W. Goebel, T. Kretzchmar-Gross, Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 22, 759–767 (2002)CrossRef W. Goebel, T. Kretzchmar-Gross, Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 22, 759–767 (2002)CrossRef
8.
go back to reference P. Massin, A. Erginay, B. Haouchine, A.B. Mehidi, M. Paques, A. Gaudric, Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software. Eur. J. Ophthalmol. 12, 102–108 (2001)CrossRef P. Massin, A. Erginay, B. Haouchine, A.B. Mehidi, M. Paques, A. Gaudric, Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software. Eur. J. Ophthalmol. 12, 102–108 (2001)CrossRef
9.
go back to reference Y. Oshima, K. Emi, S. Yamanishi, M. Motokura, Quantitative assessment of macular thickness in normal subjects and patients with diabetic retinopathy by scanning retinal thickness analyser. Br. J. Ophthalmol. 83, 54–61 (1999)CrossRef Y. Oshima, K. Emi, S. Yamanishi, M. Motokura, Quantitative assessment of macular thickness in normal subjects and patients with diabetic retinopathy by scanning retinal thickness analyser. Br. J. Ophthalmol. 83, 54–61 (1999)CrossRef
10.
go back to reference Diabetic Retinopathy Clinical Research Network, D.J. Browning, A.R. Glassman, L.P. Aiello, R.W. Beck, D.M. Brown, D.S. Fong, N.M. Bressler, R.P. Danis, J.L. Kinyoun, Q.D. Nguyen, A.R. Bhavsar, J. Gottlieb, D.J. Pieramici, M.E. Rauser, R.S. Apte, J.I. Lim, P.H. Miskala, Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 114, 525–536 (2007)CrossRef Diabetic Retinopathy Clinical Research Network, D.J. Browning, A.R. Glassman, L.P. Aiello, R.W. Beck, D.M. Brown, D.S. Fong, N.M. Bressler, R.P. Danis, J.L. Kinyoun, Q.D. Nguyen, A.R. Bhavsar, J. Gottlieb, D.J. Pieramici, M.E. Rauser, R.S. Apte, J.I. Lim, P.H. Miskala, Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 114, 525–536 (2007)CrossRef
11.
go back to reference S. Ruia, S. Saxena, Targeted screening of macular edema by spectral domain optical coherence tomography for progression of diabetic retinopathy. Indian J. Ocul. Biol. 1, 102 (2016) S. Ruia, S. Saxena, Targeted screening of macular edema by spectral domain optical coherence tomography for progression of diabetic retinopathy. Indian J. Ocul. Biol. 1, 102 (2016)
12.
go back to reference P. Phadikar, S. Saxena, S. Ruia, T.Y. Lai, C.H. Meyer, D. Eliott, The potential of spectral domain optical coherence tomography imaging based retinal biomarkers. Int. J. Retin. Vitreous. 3, 1 (2017)CrossRef P. Phadikar, S. Saxena, S. Ruia, T.Y. Lai, C.H. Meyer, D. Eliott, The potential of spectral domain optical coherence tomography imaging based retinal biomarkers. Int. J. Retin. Vitreous. 3, 1 (2017)CrossRef
13.
go back to reference S. Ahuja, S. Saxena, C.H. Meyer, J.S. Gilhotra, L. Akduman, Central subfield thickness and cube average thickness as bioimaging biomarkers for ellipsoid zone disruption in diabetic retinopathy. Int. J. Retin. Vitreous. 4, 41 (2018)CrossRef S. Ahuja, S. Saxena, C.H. Meyer, J.S. Gilhotra, L. Akduman, Central subfield thickness and cube average thickness as bioimaging biomarkers for ellipsoid zone disruption in diabetic retinopathy. Int. J. Retin. Vitreous. 4, 41 (2018)CrossRef
14.
go back to reference Early Treatment Diabetic Retinopathy Study Research Group, Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification: ETDRS report number 10. Ophthalmology 98, 786–806 (1991)CrossRef Early Treatment Diabetic Retinopathy Study Research Group, Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification: ETDRS report number 10. Ophthalmology 98, 786–806 (1991)CrossRef
15.
go back to reference A.C. Sull, L.N. Vuong, L.L. Price, V.J. Srinivasan, I. Gorczynska, J.G. Fujimoto, J.S. Schuman, J.S. Duker, Comparison of spectral/Fourier domain optical coherence tomography instruments for assessment of normal macular thickness. Retina 30, 235 (2010)CrossRef A.C. Sull, L.N. Vuong, L.L. Price, V.J. Srinivasan, I. Gorczynska, J.G. Fujimoto, J.S. Schuman, J.S. Duker, Comparison of spectral/Fourier domain optical coherence tomography instruments for assessment of normal macular thickness. Retina 30, 235 (2010)CrossRef
16.
go back to reference H. Faghihi, S. Faghihi, F. Ghassemi, Measurement of normal macular thickness using cirrus optical coherence tomography instrument in Iranian subjects with normal ocular condition. Iran. J. Ophthalmol. 25, 107–114 (2013) H. Faghihi, S. Faghihi, F. Ghassemi, Measurement of normal macular thickness using cirrus optical coherence tomography instrument in Iranian subjects with normal ocular condition. Iran. J. Ophthalmol. 25, 107–114 (2013)
17.
go back to reference A. Pokharel, G.S. Shrestha, J.B. Shrestha, Macular thickness and macular volume measurements using spectral domain optical coherence tomography in normal Nepalese eyes. Clin. Ophthalmol. 10, 511–519 (2016)CrossRef A. Pokharel, G.S. Shrestha, J.B. Shrestha, Macular thickness and macular volume measurements using spectral domain optical coherence tomography in normal Nepalese eyes. Clin. Ophthalmol. 10, 511–519 (2016)CrossRef
18.
go back to reference G. Virgili, F. Menchini, V. Murro, E. Peluso, F. Rosa, G. Casazza, Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst. Rev. 7, CD008081 (2011) G. Virgili, F. Menchini, V. Murro, E. Peluso, F. Rosa, G. Casazza, Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst. Rev. 7, CD008081 (2011)
19.
go back to reference A. Jain, S. Saxena, V.K. Khanna, R.K. Shukla, C.H. Meyer, Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus. Mol. Vis. 19, 176017–176068 (2013) A. Jain, S. Saxena, V.K. Khanna, R.K. Shukla, C.H. Meyer, Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus. Mol. Vis. 19, 176017–176068 (2013)
20.
go back to reference T. Otani, Y. Yamaguchi, S. Kishi, Correlation between visual acuity and foveal microstructural changes in diabetic macular edema. Retina 30, 774–780 (2010)CrossRef T. Otani, Y. Yamaguchi, S. Kishi, Correlation between visual acuity and foveal microstructural changes in diabetic macular edema. Retina 30, 774–780 (2010)CrossRef
21.
go back to reference H.J. Shin, S.H. Lee, H. Chung, H.C. Kim, Association between photoreceptor integrity and visual outcome in diabetic macular edema. Graefes Arch. Clin. Exp. Ophthalmol. 250, 61–70 (2012)CrossRef H.J. Shin, S.H. Lee, H. Chung, H.C. Kim, Association between photoreceptor integrity and visual outcome in diabetic macular edema. Graefes Arch. Clin. Exp. Ophthalmol. 250, 61–70 (2012)CrossRef
22.
go back to reference N. Mishra, S. Saxena, R.K. Shukla, V. Singh, C.H. Meyer, P. Kruzliak, V.K. Khanna, Association of serum N ε-Carboxy methyl lysine with severity of diabetic retinopathy. J. Diabetes Complicat. 30, 511–517 (2016)CrossRef N. Mishra, S. Saxena, R.K. Shukla, V. Singh, C.H. Meyer, P. Kruzliak, V.K. Khanna, Association of serum N ε-Carboxy methyl lysine with severity of diabetic retinopathy. J. Diabetes Complicat. 30, 511–517 (2016)CrossRef
23.
go back to reference S. Sharma, S. Saxena, K. Srivastav, R.K. Shukla, N. Mishra, C.H. Meyer, P. Kruzliak, V.K. Khanna, Nitric oxide and oxidative stress is associated with severity of diabetic retinopathy and retinal structural alterations. Clin. Exp. Ophthalmol. 43, 429–436 (2015)CrossRef S. Sharma, S. Saxena, K. Srivastav, R.K. Shukla, N. Mishra, C.H. Meyer, P. Kruzliak, V.K. Khanna, Nitric oxide and oxidative stress is associated with severity of diabetic retinopathy and retinal structural alterations. Clin. Exp. Ophthalmol. 43, 429–436 (2015)CrossRef
24.
go back to reference J. Liang, W. Lei, J. Cheng, Correlations of blood lipids with early changes in macular thickness in patients with diabetes. J. Fr. Ophtalmol. S0181-5512(18)30537-0 (2019). J. Liang, W. Lei, J. Cheng, Correlations of blood lipids with early changes in macular thickness in patients with diabetes. J. Fr. Ophtalmol. S0181-5512(18)30537-0 (2019).
25.
go back to reference S. Saxena, S. Ruia, S. Prasad, A. Jain, N. Mishra, S.M. Natu, C.H. Meyer, J.S. Gilhotra, P. Kruzliak, L. Akduman, Increased serum levels of urea and creatinine are surrogate markers for disruption of retinal photoreceptor external limiting membrane and inner segment ellipsoid zone in type 2 diabetes mellitus. Retina 37, 344–349 (2017)CrossRef S. Saxena, S. Ruia, S. Prasad, A. Jain, N. Mishra, S.M. Natu, C.H. Meyer, J.S. Gilhotra, P. Kruzliak, L. Akduman, Increased serum levels of urea and creatinine are surrogate markers for disruption of retinal photoreceptor external limiting membrane and inner segment ellipsoid zone in type 2 diabetes mellitus. Retina 37, 344–349 (2017)CrossRef
26.
go back to reference S. Saxena, K. Srivastav, L. Akduman, Spectral domain optical coherence tomography based alterations in macular thickness and inner segment ellipsoid are associated with severity of diabetic retinopathy. Int. J. Ophthalmol. Clin. Res. 2, 7 (2015)CrossRef S. Saxena, K. Srivastav, L. Akduman, Spectral domain optical coherence tomography based alterations in macular thickness and inner segment ellipsoid are associated with severity of diabetic retinopathy. Int. J. Ophthalmol. Clin. Res. 2, 7 (2015)CrossRef
27.
go back to reference D.J. Browning, C.M. Fraser, S. Clark, The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology 115, 533–539 (2008)CrossRef D.J. Browning, C.M. Fraser, S. Clark, The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology 115, 533–539 (2008)CrossRef
28.
go back to reference L. Pelosini, C.C. Hull, J.F. Boyce, D. McHugh, M.R. Stanford, J. Marshall, Optical coherence tomography may be used to predict visual acuity in patients with macular edema. Investig. Ophthalmol. Vis. Sci. 52, 2741–2748 (2011)CrossRef L. Pelosini, C.C. Hull, J.F. Boyce, D. McHugh, M.R. Stanford, J. Marshall, Optical coherence tomography may be used to predict visual acuity in patients with macular edema. Investig. Ophthalmol. Vis. Sci. 52, 2741–2748 (2011)CrossRef
29.
go back to reference H. Alkuraya, D. Kangave, A.M. Abu El-Asrar, The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema. Int. Ophthalmol. 26, 93–99 (2005)CrossRef H. Alkuraya, D. Kangave, A.M. Abu El-Asrar, The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema. Int. Ophthalmol. 26, 93–99 (2005)CrossRef
30.
go back to reference J. Olson, P. Sharp, K. Goatman, G. Prescott, G. Scotland, A. Fleming, S. Philip, C. Santiago, S. Borooah, D. Broadbent, V. Chong, P. Dodson, S. Harding, G. Leese, C. Styles, K. Swa, H. Wharton, Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study. Health Technol. Assess. 17, 1–142 (2013)CrossRef J. Olson, P. Sharp, K. Goatman, G. Prescott, G. Scotland, A. Fleming, S. Philip, C. Santiago, S. Borooah, D. Broadbent, V. Chong, P. Dodson, S. Harding, G. Leese, C. Styles, K. Swa, H. Wharton, Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study. Health Technol. Assess. 17, 1–142 (2013)CrossRef
Metadata
Title
Spectral domain optical coherence tomography based imaging biomarkers for diabetic retinopathy
Authors
Sandeep Saxena
Martin Caprnda
Surabhi Ruia
Senthamizh Prasad
Ankita
Julia Fedotova
Peter Kruzliak
Vladimir Krasnik
Publication date
01-12-2019
Publisher
Springer US
Published in
Endocrine / Issue 3/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02093-7

Other articles of this Issue 3/2019

Endocrine 3/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.